Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing.
about
Mesenchymal Stem Cell Therapy for Cutaneous WoundsAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsMesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cellsProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeMaresin biosynthesis and identification of maresin 2, a new anti-inflammatory and pro-resolving mediator from human macrophagesProresolving lipid mediators and diabetic wound healingIdentification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite.Maresin-like lipid mediators are produced by leukocytes and platelets and rescue reparative function of diabetes-impaired macrophages.14S,21R-dihydroxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds.Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes.Generation and dietary modulation of anti-inflammatory electrophilic omega-3 fatty acid derivatives.Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions.Novel 14S,21-dihydroxy-docosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure.14S,21R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury.Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury.Arachidonic acid-derived signaling lipids and functions in impaired healing.The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype.Immunohistological localization of endogenous unlabeled stem cells in wounded skin.Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid12/15-Lipoxygenase deficiency reduces densities of mesenchymal stem cells in the dermis of wounded and unwounded skinBioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis.Surgical Denervation of Specific Cutaneous Nerves Impedes Excisional Wound Healing of Small Animal Ear Pinnae.Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease.Lipid Emulsion Enriched in Omega-3 PUFA Accelerates Wound Healing: A Placebo-Controlled Animal Study.Fatty acids and related lipid mediators in the regulation of cutaneous inflammation.CYP2E1 oxidises 14(S)-HDHA to 14(S);21(R)-diHDHA and 14(S);21(S)-diHDHACYP2E1 oxidises 14(R)-HDHA to 14(R);21(R)-diHDHA and 14(R);21(S)-diHDHA
P2860
Q26860887-1E86E44E-0166-43A4-9481-EB99C856C7D6Q27014988-FB08BD96-8330-42CE-97DF-6B147B4A0910Q28069171-2C4420E3-C6A6-40A5-9B0A-255A400222DCQ28277101-3C69921B-A2F9-4A7A-BDC9-134050BE3EC5Q28387661-D4593B4B-3B76-4663-BB1F-E96F7701842EQ28390502-7BFF05FC-7F2A-435E-89D4-9C7A9F5A7156Q33683848-704A36F0-106B-4664-A4F4-7C02274CBFBDQ34428681-3DDDC0E7-5771-472A-B2D7-393E23D22C32Q34437431-8E86427D-97D0-4FCF-9FC6-79FAC6BE0FBBQ34575934-DC8A28D6-9058-49AF-91B2-55CC53DFFD28Q34627478-C2736B42-68B0-4B03-B5CB-046BDD4764DBQ35149408-06692945-FEBF-44B8-AA39-33445310F1CAQ35235688-9C46E525-C7D2-4B5E-A94A-F8AADC914FFFQ35841779-304360AF-E335-433F-89DA-60EE8B5B0FB8Q35895293-349F133D-0ADA-4B46-B3BE-54EB5574BDEEQ36572864-6C2BF094-A40F-453F-88DD-14B7CB71751FQ36815776-F01D196F-F1A5-44C2-BFD2-90CC874A05D8Q36945083-9B4B55FF-9267-4F09-BD0E-CFDB7FFFC36DQ37664266-5CBF167D-FB6E-4F16-B2BE-02F798EF93A9Q39556645-070632F4-D74C-40B4-AB28-7D0DE3E448E1Q41969776-FF776700-F2B6-4989-BF5B-4DB5F03C94AEQ48104675-A965476D-263B-4B74-A546-81F2E4A8BA56Q48326701-F0E87A0F-7464-42B7-8257-497A00A1C573Q49506046-DAEB544C-4ABE-4C29-9BC3-1E5F39363AB9Q49630148-278E8B6A-0353-485F-9DD3-2B9F42A8F325Q50058801-E9BF8835-D60C-4DB0-A0DC-D88B585DB907Q55216530-35F73B84-99E1-41AC-A97A-D5D1DBB81B1AQ55216531-5133BD33-6668-44B4-B9C9-0724021F611A
P2860
Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel 14,21-dihydroxy-docosahe ...... enhancement of wound healing.
@ast
Novel 14,21-dihydroxy-docosahe ...... enhancement of wound healing.
@en
type
label
Novel 14,21-dihydroxy-docosahe ...... enhancement of wound healing.
@ast
Novel 14,21-dihydroxy-docosahe ...... enhancement of wound healing.
@en
prefLabel
Novel 14,21-dihydroxy-docosahe ...... enhancement of wound healing.
@ast
Novel 14,21-dihydroxy-docosahe ...... enhancement of wound healing.
@en
P2093
P2860
P921
P356
P1476
Novel 14,21-dihydroxy-docosahe ...... enhancement of wound healing.
@en
P2093
P2860
P304
P356
10.1194/JLR.M000059
P577
2009-11-05T00:00:00Z